DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Robert Kolodziejczyk

R&D Director

Green Zebras

Wroclaw, Poland

23 profile visitsCompanies/Industry

We are actively sourcing external opportunities for co-development, in-licensing, or joint research initiatives in veterinary medicine (dogs, cats, horses). I would welcome the opportunity to discuss potential synergies.

My organisation

Green Zebras focuses on therapies for companion animals (dogs, cats, and horses), enabling partners to expand human drug development programmes into an attractive and complementary veterinary market. In veterinary medicine projects, Green Zebras provides end-to-end support throughout the research process, up to market launch as a medicinal product for companion animals (dogs, cats, and horses). For early-stage translational medicine projects, Green Zebras offers a collaboration model that includes the full package of preclinical studies in animals. Partners gain unrestricted access to the complete set of preclinical data to support further development of therapies for humans, while Green Zebras retains the rights to develop the molecule in the veterinary segment. For advanced projects already at the clinical stage, Green Zebras offers collaboration opportunities to support the development and commercialisation of the molecule for veterinary applications. To this end, the company welcomes discussions with scientists and research teams who recognise the therapeutic potential of their work and are interested in further development and commercialisation.
Read more

About me

I have a strong background in protein chemistry and structural biology, with over 10 years of experience in R&D within human drug discovery and development programs. I currently serve as R&D Director at Green Zebras, where we are strategically expanding our portfolio to include innovative therapeutic candidates for companion animals (dogs, cats, and horses).

Social media

Skills

  • R&D
  • Protein Chemistry
  • Structural Biology

Interests

  • Cooperation
  • In-licensing
  • co-development

Additional questions

Interests

VaccinesRegulatory AffairsPharmaceutical / TherapeuticsDiagnosticsCompanion animalsOther

What is your primary goal for attending this event?

Networking with industry professionalsExploring potential collaborationsLearning about the latest trends in healthtech

Marketplace (1)

  • Partnership

    Drug development for companion animals.

    Seeking collaboration opportunities to develop scientific projects based on therapeutic solutions with high commercialisation potential in veterinary medicine (in-licensing, co-development).

    Author

    Robert Kolodziejczyk

    R&D Director at Green Zebras

    Wroclaw, Poland